These findings suggest that OLAH dysregulation in the placenta is unlikely to be associated with changes in these anti-angiogenic and angiogenic factors that are synonymous with preeclampsia, and hence would not be a suitable target for controlling levels of these factors in disease. Here, OLAH is linked to preeclampsia.